Creation of the Notes. In accordance with Section 301 of the Base Indenture, the Company hereby creates the Notes as a separate series of its securities issued pursuant to the Indenture. The Notes shall be issued initially in an aggregate principal amount of $600,000,000, except as permitted by Sections 304, 305 or 306 of the Base Indenture.
Creation of the Notes. In accordance with Section 3.01 of the Indenture, the Issuers hereby create the Notes as separate series of their Securities issued pursuant to the Indenture. The Notes shall be issued initially in an aggregate principal amount of $250,000,000.
Creation of the Notes. Pursuant to Sections 201 and 301 of the Original Indenture, there is hereby created a new series of Securities designated as the "6.50% Senior Notes due 2014" and which are sometimes herein referred to as the "Notes." The Notes (including, without limitation, the Exchange Notes and Private Exchange Notes) shall be in substantially the form set forth in Exhibit A hereto, with such changes therein as may be authorized by any officer of the Company executing any Notes by manual or facsimile signature, such approval to be conclusively evidenced by the execution thereof by such officer. The Notes shall have the following terms:
(a) The aggregate principal amount of the Notes which may be authenticated and delivered under the Indenture is limited to $100,000,000, except for Notes authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Notes pursuant to Sections 304, 305, 306, 905 or 1107 of the Original Indenture (including, without limitation, Exchange Notes or Private Exchange Notes issued in exchange for other Notes); provided, however, that such series may be re-opened by the Company for the issuance of Additional Notes, so long as any such Additional Notes have the same form and terms (other than date of issuance and the date from which interest thereon shall begin to accrue and except that the form of such Additional Notes may refer to a different Registration Rights Agreement than the Notes issued on the Closing Date and such Additional Notes, if issued pursuant to a registration statement which is effective under the Securities Act, need not bear the Private Placement Legend and may omit the paragraph included in Exhibit A hereto which refers to the Registration Rights Agreement), and carry the same right to receive accrued and unpaid interest, as the Notes theretofore issued; provided, however, that, notwithstanding the foregoing, such series may not be re-opened if the Company has effected defeasance or covenant defeasance with respect to the Notes pursuant to Sections 402(2) or 402(3), respectively, of the Original Indenture or has effected satisfaction and discharge with respect to the Notes pursuant to Section 401 of the Original Indenture; and provided, further, that no Additional Notes may be issued at a price that would cause such Additional Notes to have "original issue discount" within the meaning of Section 1273 of the Internal Revenue Code of 1986, as amended.
(b) The Notes are to be issuable onl...
Creation of the Notes. In accordance with Section 301 of the Base Indenture, the Operating Partnership hereby creates the Notes as a separate series of its senior unsecured debt securities, entitled “4.900% Senior Notes due 2029”, issued pursuant to the Indenture. The Notes shall initially be limited to an aggregate principal amount equal to $400,000,000, subject to the exceptions set forth in Section 301(2) of the Base Indenture and Section 1.4(f) hereof.
Creation of the Notes. In accordance with Sections 2.1 and 3.1 of the Base Indenture, the Company hereby creates the Notes as a separate series of its Securities issued pursuant to the Indenture, as supplemented by this First Supplemental Indenture. The Notes shall be issued initially in an aggregate principal amount of $[●].
Creation of the Notes. In accordance with Section 2.1 of the Base Indenture, the Company hereby creates each of the 2029 Notes, the 2032 Notes and the 2052 Notes as a separate series of its Securities issued pursuant to the Indenture. The 2029 Notes shall be issued initially in an aggregate principal amount of $1,000,000,000. The 2032 Notes shall be issued initially in an aggregate principal amount of $850,000,000. The 2052 Notes shall be issued initially in an aggregate principal amount of $1,150,000,000.
Creation of the Notes. In accordance with Section 2.1 of the Indenture, the Company hereby creates each of the 2025 Notes and the 2045 Notes as a separate series of its Securities issued pursuant to the Indenture. The 2025 Notes shall be issued initially in an aggregate principal amount of $500,000,000. The 2045 Notes shall be issued initially in an aggregate principal amount of $250,000,000.
Creation of the Notes. Pursuant to the terms hereof and the Indenture, the Company hereby creates a series of its Notes known as the "8.125% Senior Notes due 2011" each of which shall be deemed Securities for all purposes of the Indenture.
Creation of the Notes. In accordance with Section 2.3 of the Original Indenture, the Issuer hereby creates each of the 2025 Notes and the 2029 Notes as a separate series of its Securities issued pursuant to the Indenture. The 2025 Notes shall be issued initially in an aggregate principal amount of €500,000,000 and the 2029 Notes shall be issued initially in an aggregate principal amount of €500,000,000, except as permitted by Sections 2.8, 2.9 or 2.11 of the Original Indenture.
Creation of the Notes. In accordance with Section 301 of the Base Indenture, the Company hereby creates the Notes as a separate series of its securities issued pursuant to the Indenture. The Notes initially shall be limited to an aggregate principal amount of €700,000,000 (except in each case for Notes authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Notes of or within the series pursuant to Section 304, 305, 306, 906, 1107 or 1305 of the Base Indenture); provided, the Company may increase such aggregate principal amount upon the authorization of the board of directors of the Company to do so from time to time.
